European Prostate Cancer Awareness Day 2025

Every year, an estimated 450,000 men in Europe are diagnosed with prostate cancer, and 107,000 die as a result of the disease. And then there’s the price we all pay: Prostate cancer costs Europeans € 9 billion each year, with healthcare accounting for € 5.8 billion.

 

Despite this, most European countries still do not have prostate screening programmes in place.

 

The European Association of Urology, the European Cancer Organisation, Europa Uomo, and the Global Action on Men’s Health are calling on the European Union to address prostate cancer in Europe’s Beating Cancer Plan.

 

On European Prostate Cancer Awareness Day, experts, policy makers, and patient representatives will gather to explore how public policies can dramatically improve screening and early detection.

 

The event takes place in the European Parliament on Wednesday 3 September, 14:30-16:00 CEST. Register here.

03 September 2025 14:30 - 16:00

European Parliament, Brussels

Event page visual

In Northern and Western Europe, prostate cancer is either the leading or second leading cause of cancer death in men. It is the most frequently occurring male cancer across Europe and creates a significant strain on healthcare systems.

Most European countries already have screening programmes for cervical, breast and colorectal cancer. Then, three years ago, the Council of the European Union updated its Cancer Screening Recommendations to include prostate cancer.

There is good evidence that PSA tests and MRI (Magnetic Resonance Imaging) can save lives. But how do we create policies and programmes that make these tests readily available?

To join this informative event, please register your interest in the form below.



 

Event page visual

Speakers

  • Giorgos Georgiou MEP Member Committee on Public Health, member of the Intergroup on Cancer & Rare Diseases
  • Michalis Hadjipantela MEP Member Committee on Public Health, member of the Intergroup on Cancer & Rare Diseases
  • Dr Erik Briers Vice-chair, Europa Uomo
  • Dr Arunah Chandran Public Health Officer at the International Agency for Research on Cancer (IARC/WHO)
  • Prof. Hein Van Poppel Chair EAU Policy Office, European Association of Urology (EAU)
  • Prof. Monique Roobol Head scientific research office Department of Urology at Erasmus Medical Centre Rotterdam
show all speakers (11)

Speakers

  • Giorgos Georgiou MEP Member Committee on Public Health, member of the Intergroup on Cancer & Rare Diseases
  • Michalis Hadjipantela MEP Member Committee on Public Health, member of the Intergroup on Cancer & Rare Diseases
  • Dr Erik Briers Vice-chair, Europa Uomo
  • Dr Arunah Chandran Public Health Officer at the International Agency for Research on Cancer (IARC/WHO)
  • Prof. Hein Van Poppel Chair EAU Policy Office, European Association of Urology (EAU)
  • Prof. Monique Roobol Head scientific research office Department of Urology at Erasmus Medical Centre Rotterdam
show all speakers (11)
  • Giorgos Georgiou MEP Member Committee on Public Health, member of the Intergroup on Cancer & Rare Diseases
  • Michalis Hadjipantela MEP Member Committee on Public Health, member of the Intergroup on Cancer & Rare Diseases
  • Dr Erik Briers Vice-chair, Europa Uomo
  • Dr Arunah Chandran Public Health Officer at the International Agency for Research on Cancer (IARC/WHO)
  • Prof. Hein Van Poppel Chair EAU Policy Office, European Association of Urology (EAU)
  • Prof. Monique Roobol Head scientific research office Department of Urology at Erasmus Medical Centre Rotterdam
  • Dr Ausvydas Patasius Professor, Epidemiologist, Vilnus University
  • Dr Rebecka Arnsrud Godtman Associate Professor, Urologist, University of Gothenburg
  • Domenico Fiorenza Policy Officer, DG Sante, European Commission
  • Agnieska Kinsner-Ovaskainen Scientific Officer, European Commission, Joint Research Centre (JRC)
  • Peter Baker Chief Executive, Global Action on Men’s Health (GAMH)

Speakers

  • Giorgos Georgiou MEP Member Committee on Public Health, member of the Intergroup on Cancer & Rare Diseases
  • Michalis Hadjipantela MEP Member Committee on Public Health, member of the Intergroup on Cancer & Rare Diseases
  • Dr Erik Briers Vice-chair, Europa Uomo
  • Dr Arunah Chandran Public Health Officer at the International Agency for Research on Cancer (IARC/WHO)
  • Prof. Hein Van Poppel Chair EAU Policy Office, European Association of Urology (EAU)
  • Prof. Monique Roobol Head scientific research office Department of Urology at Erasmus Medical Centre Rotterdam
show all speakers (11)

3 September
14:30-16:00
Spinelli Building – Room 1G2
European Parliament, Brussels

 

Welcome and Introductions

  

Giorgos Georgiou MEP, Member Committee on Public Health, member of the Intergroup on Cancer & Rare Diseases

Michalis Hadjipantela MEP, Member Committee on Public Health, member of the Intergroup on Cancer & Rare Diseases

 Setting the Scene

  

Dr Erik Briers, vice-chair, Europa Uomo

The patient voice on prostate cancer policy making and the need for screening – 10 mins

Dr Arunah Chandran, Public Health Officer at the International Agency for Research on Cancer (IARC/WHO)

IARC action on screening and early detection of Prostate Cancer and the 3rd Cancer Screening Report

Prostate Cancer Implementation Responses across Europe

  

Professor Hein Van Poppel, Chair EAU Policy Office, European Association of Urology (EAU) and co-chair of the Men & Cancer Workstream at ECO

Opportunities arising from the EU Cancer Screening Recommendations – the PRAISE U project - 10 mins

Professor Monique Roobol, Head scientific research office Department of Urology at Erasmus Medical Centre Rotterdam

PRAISE U pilot sites – what we are learning so far – 10 mins

Dr Ausvydas Patasius, Professor, Epidemiologist, Vilnus University

The Lithuanian pilot and applying the PRAISE U algorithm to national policy – 10 mins (TBC)

Vytenis Andriukaitis MEP, Member Committee on Public Health

Dr Rebecka Arnsrud Godtman, Associate Professor, Urologist, University of Gothenburg

The OPT experience from Swedish regions – 10 mins (TBC)

Panel with European Policy Makers response

  

Domenico Fiorenza, Policy Officer, DG Sante, European Commission

Europe’s Beating Cancer Plan – EU action on Prostate Cancer Screening – 7 mins (TBC)

Agnieska Kinsner-Ovaskainen, Scientific Officer, European Commission, Joint Research Centre (JRC)

European Commission initiatives on cancer screening and follow-up care– 7 mins

Global policy making on Prostate Cancer

  

Peter Baker, Chief Executive, Global Action on Men’s Health (GAMH) and co-chair of the Men & Cancer Workstream at ECO

Presentation of the GAMH Prostate Cancer report and the call for the Global Initiative on PCa 7 mins

Speakers

  • Giorgos Georgiou MEP Member Committee on Public Health, member of the Intergroup on Cancer & Rare Diseases
  • Michalis Hadjipantela MEP Member Committee on Public Health, member of the Intergroup on Cancer & Rare Diseases
  • Dr Erik Briers Vice-chair, Europa Uomo
  • Dr Arunah Chandran Public Health Officer at the International Agency for Research on Cancer (IARC/WHO)
  • Prof. Hein Van Poppel Chair EAU Policy Office, European Association of Urology (EAU)
  • Prof. Monique Roobol Head scientific research office Department of Urology at Erasmus Medical Centre Rotterdam
show all speakers (11)

Speakers

  • Giorgos Georgiou MEP Member Committee on Public Health, member of the Intergroup on Cancer & Rare Diseases
  • Michalis Hadjipantela MEP Member Committee on Public Health, member of the Intergroup on Cancer & Rare Diseases
  • Dr Erik Briers Vice-chair, Europa Uomo
  • Dr Arunah Chandran Public Health Officer at the International Agency for Research on Cancer (IARC/WHO)
  • Prof. Hein Van Poppel Chair EAU Policy Office, European Association of Urology (EAU)
  • Prof. Monique Roobol Head scientific research office Department of Urology at Erasmus Medical Centre Rotterdam
show all speakers (11)